GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
54 hedge funds and large institutions have $44.5M invested in Genocea Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
Holders
54
Holding in Top 10
1
Calls
$1.3M
Puts
–
Top Buyers
| 1 | +$3.02M | |
| 2 | +$730K | |
| 3 | +$343K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$244K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$227K |
Top Sellers
| 1 | -$3.18M | |
| 2 | -$561K | |
| 3 | -$509K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$509K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$277K |